| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w24536 |
| 来源ID | Working Paper 24536 |
| The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries | |
| Frank R. Lichtenberg | |
| 发表日期 | 2018-04-23 |
| 出版年 | 2018 |
| 语种 | 英语 |
| 摘要 | This study employs a two-way fixed effects research design to measure the mortality impact and cost-effectiveness of cancer drugs: it analyzes the correlation across 36 countries between relative mortality from 19 types of cancer in 2015 and the relative number of drugs previously launched in that country to treat that type of cancer, controlling for relative incidence. One additional drug for a cancer site launched during 2006-2010 is estimated to have reduced the number of 2015 disability-adjusted life years (DALYs) lost due to cancer at that site by 5.8%. The estimated cost per life-year gained at all ages in 2015 from cancer drugs launched during 2006-2010 is $1635. We estimate that drugs launched during the entire 1982-2010 period reduced the number of cancer DALYs lost in 2015 by about 23%. In the absence of new drug launches during 1982-2010, there would have been 26.3 million additional DALYs lost in 2015. |
| 主题 | Health, Education, and Welfare ; Health ; Labor Economics ; Demography and Aging ; Industrial Organization ; Industry Studies ; Development and Growth ; Innovation and R& ; D |
| URL | https://www.nber.org/papers/w24536 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/582209 |
| 推荐引用方式 GB/T 7714 | Frank R. Lichtenberg. The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries. 2018. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w24536.pdf（552KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
| 个性服务 |
| 推荐该条目 |
| 保存到收藏夹 |
| 导出为Endnote文件 |
| 谷歌学术 |
| 谷歌学术中相似的文章 |
| [Frank R. Lichtenberg]的文章 |
| 百度学术 |
| 百度学术中相似的文章 |
| [Frank R. Lichtenberg]的文章 |
| 必应学术 |
| 必应学术中相似的文章 |
| [Frank R. Lichtenberg]的文章 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
